Bilimsel çalışmalar

Doç. Dr. Sema Seçilmiş

36 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Initial clinical and laboratory findings of patients diagnosed with HIV in a hematology outpatient clinic: a retrospective analysis

    Journal of Health Sciences and Medicine, 2026

    DOI 10.32322/jhsm.1783841 Açık erişimli tam metinKaynak: OpenAlex

  2. Impact of Dyslipidemia on Allogeneic Transplantation Outcomes and Cardiovascular Mortality in Patients with Acute Leukemias in the Post-Transplant Cyclophosphamide Era

    Pharmaceuticals (Basel, Switzerland), 2026

    DOI 10.3390/ph19040529 PMID 42075786 Açık erişimli tam metinKaynak: Europe PMC

  3. Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study

    Journal of clinical medicine, 2026

    DOI 10.3390/jcm15020854 PMID 41598791 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

  4. Prognostic value of the CONUT score in newly diagnosed diffuse large B‑cell lymphoma

    Oncology Letters, 2026

    DOI 10.3892/ol.2026.15805 PMID 42614724 Açık erişimli tam metinKaynak: OpenAlex

  5. Cholesterol Levels Are Not Associated with Peripheral Blood Stem Cell Mobilization in Healthy Donors

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14176239 PMID 40943998 Açık erişimli tam metinKaynak: ORCID

  6. Characteristics and Outcomes of Patients with Acute Promyelocytic Leukemia: A Single-center Experience

    Acta haematologica oncologica Turcica., 2025

    DOI 10.4274/ahot.galenos.2025.2025-6-1 Açık erişimli tam metinKaynak: OpenAlex

  7. Cladribine Treatment Outcomes in Hairy Cell Leukemia: A Single-center Experience

    Acta haematologica oncologica Turcica., 2025

    DOI 10.4274/ahot.galenos.2025.2025-7-4 Açık erişimli tam metinKaynak: OpenAlex

  8. LANGERHANS CELL HISTIOCYTOSIS: SINGLE-CENTER EXPERIENCE

    Hematology Transfusion and Cell Therapy, 2025

    DOI 10.1016/j.htct.2025.106121 Açık erişimli tam metinKaynak: OpenAlex

  9. Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis

    Turkish Journal of Hematology, 2024

    DOI 10.4274/tjh.galenos.2024.2023.0450 PMID 39501735 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  10. Early Tapering of Cyclosporine Is Feasible in Haploidentical Stem Cell Transplantation: A Single Center Experience

    Clinical transplantation, 2024

    DOI 10.1111/ctr.15376 PMID 39031699 1 atıf (Europe PMC) Kaynak: ORCID

  11. Evaluation of oral manifestations and head and neck lymphadenopathy in newly diagnosed acute leukemia patients

    Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry, 2024

    DOI 10.1111/scd.12941 PMID 37994175 Açık erişimli tam metinKaynak: ORCID

  12. Is an earlier strategy for harvesting peripheral blood stem cells in healthy allogeneic donors feasible?

    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2024

    DOI 10.1016/j.transci.2024.103956 PMID 38810408 Kaynak: ORCID

  13. Is Ruxolitinib an Effective and Safe Therapy for Chronic Myeloproliferative Diseases?

    Acta Oncologica Turcica, 2024

    DOI 10.5505/aot.2023.46656 Açık erişimli tam metinKaynak: OpenAlex

  14. Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye

    Turkish Journal of Hematology, 2023

    DOI 10.4274/tjh.galenos.2023.2023.0029 PMID 37961952 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  15. Uric Acid and Multiple Myeloma, Unexplored Association

    Acta Oncologica Turcica, 2023

    DOI 10.5505/aot.2023.25901 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  16. Characteristics and Outcome of Patients with Chronic Myelomonocytic Leukemia: Experience of a Single Center

    Acta Oncologica Turcica, 2023

    DOI 10.5505/aot.2023.20082 Açık erişimli tam metinKaynak: OpenAlex

  17. Efficiency of intravenous iron carboxymaltose in patients with iron-deficiency anemia due to heavy menstrual bleeding: a single-center experience

    PubMed, 2022

    DOI 10.26355/eurrev_202205_28843 PMID 35647829 4 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  18. Pregnancy outcomes in female cancer survivors after hematopoietic stem cell transplantation

    PubMed, 2022

    DOI 10.26355/eurrev_202202_28008 PMID 35179765 5 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  19. Transformed Lymphomas: Is It Really Rare ?

    Acta Oncologica Turcica, 2022

    DOI 10.5505/aot.2022.56689 Açık erişimli tam metinKaynak: OpenAlex

  20. Immune Thrombocytopenia: A Disease With Many Unresolved Questions

    Acta Oncologica Turcica, 2022

    DOI 10.5505/aot.2022.89166 Açık erişimli tam metinKaynak: OpenAlex

  21. Evaluation of seasonality in the diagnosis of diffuse large B cell lymphoma in Turkey

    Journal of Health Sciences and Medicine, 2021

    DOI 10.32322/jhsm.828027 Açık erişimli tam metinKaynak: ORCID

  22. Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma

    Leukemia research, 2021

    DOI 10.1016/j.leukres.2021.106700 PMID 34481125 8 atıf (Europe PMC) Kaynak: ORCID

  23. Combination of Venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia: A case series from a single center.

    PubMed, 2021

    PMID 34761613 1 atıf (OpenAlex) Kaynak: OpenAlex

  24. Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations

    Medicine, 2020

    DOI 10.1097/md.0000000000019627 PMID 32243389 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  25. Combination of Venetoclax and Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: Single-Center Clinical Experience

    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020

    Kaynak: ORCID

  26. One Year Remission with Allogeneic Stem Cell Transplantation After Achieving Complete Response by Polatuzumab Vedotin for the Treatment of Refractory Diffuse Large B-Cell Lymphoma

    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020

    Kaynak: ORCID

  27. The Coexistence of Hyperimmunoglobulin E Syndrome and Myelodysplastic Syndrome

    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020

    Kaynak: ORCID

  28. AML-360: The Coexistence of Hyperimmunoglobulin E Syndrome and Myelodysplastic Syndrome

    Clinical Lymphoma Myeloma & Leukemia, 2020

    DOI 10.1016/s2152-2650(20)30767-9 Kaynak: OpenAlex

  29. AML-212: Combination of Venetoclax and Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: Single-Center Clinical Experience

    Clinical Lymphoma Myeloma & Leukemia, 2020

    DOI 10.1016/s2152-2650(20)30735-7 Kaynak: OpenAlex

  30. ABCL-037: One Year Remission with Allogeneic Stem Cell Transplantation After Achieving Complete Response by Polatuzumab Vedotin for the Treatment of Refractory Diffuse Large B-Cell Lymphoma

    Clinical Lymphoma Myeloma & Leukemia, 2020

    DOI 10.1016/s2152-2650(20)30864-8 Kaynak: OpenAlex

  31. Behcet's disease and IgA nephropathy

    Rheumatology international, 2012

    DOI 10.1007/s00296-011-2051-3 PMID 21785954 10 atıf (Europe PMC) Kaynak: ORCID

  32. QT INTERVAL DISPERSION AMONG CHRONIC AMBULATORY PERITONEAL DIALYSIS PATIENTS AND ASSOCIATION WITH IRON STORES

    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012

    Kaynak: ORCID

  33. Mucocutaneous manifestations in inflammatory bowel disease

    Inflamm Bowel Dis, 2009

    DOI 10.1002/ibd.20807 PMID 19023896 52 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  34. Pro-Hepcidin Levels in Peritoneal Dialysis and Hemodialysis Patients

    Dialysis & Transplantation, 2009

    DOI 10.1002/dat.20297 5 atıf (OpenAlex) Kaynak: ORCID

  35. Endoscopic Sphincteroplasty with Large Balloon Dilatation for Extraction of Difficult Common Bile Duct Stones

    Digestive Diseases and Sciences, 2007

    DOI 10.1007/s10620-007-0060-6 PMID 17940901 10 atıf (OpenAlex) Kaynak: OpenAlex

  36. Hepatotoxicity after low-dose cyclophosphamide therapy

    Southern medical journal, 2006

    DOI 10.1097/01.smj.0000251467.62842.ad PMID 17233202 15 atıf (Europe PMC) Kaynak: ORCID